Alpha-Fetoprotein (AFP) in BloodAFP (Alpha-Fetoprotein) Test, MSAFP (Maternal Serum Alpha-Fetoprotein) Test What To Think About- The level of AFP in the blood is often used in
a maternal serum triple or quadruple screening test. Usually done between 15
and 20 weeks, these tests check the levels of three or four substances in a
pregnant woman's blood. The triple screen checks alpha-fetoprotein (AFP), beta
human chorionic gonadotropin (beta-hCG), and a type of estrogen (unconjugated
estriol, or uE3). The quad screen checks these substances and the level of the
hormone inhibin A. The levels of these substances—along with a woman's age and
other factors—help the doctor estimate the chance that the baby may have
certain problems or birth defects. For more information about estriol and hCG,
see the medical tests
Estrogens,
Human Chorionic Gonadotropin (hCG), and
Hormone Inhibin A.
- AFP is a screening
test to look for possible problems in your unborn baby.
Other tests must always be done if the AFP results are abnormal. An ultrasound
will likely be done if the AFP is abnormal. If an ultrasound cannot find the
cause of the abnormal AFP, an amniocentesis may be recommended. For more
information, see the medical test
Fetal Ultrasound.
- A normal AFP result does
not mean a
neural tube defect or Down syndrome is not
present.
- The amount of AFP in the amniotic fluid may also be
measured using
amniocentesis. Most women have normal AFP levels in
the amniotic fluid, even though the levels may be abnormal in their blood.
These women are at low risk of having a fetus with a neural tube defect. For
more information, see the medical test
Amniocentesis.
- If abnormal levels of AFP
are found, talk with your doctor or a
genetic counselor. AFP test results can be abnormal,
even when nothing is wrong with the baby.
- In people with liver
cancer or other types of cancer, a decrease in AFP may mean treatment is
working.
Go to previous section | Go to top of page | Go to next section |
| | Author: | Jan Nissl, RN, BS | Last Updated: May 29, 2006 | | Medical Review: | Renée M. Crichlow, MD - Family Medicine Siobhan M. Dolan, MD, MPH - Reproductive Genetics | © 1995-2008 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.
| 
| |
| |